Scientists test 3-Pronged attack to cure HIV
NCT ID NCT03619278
Summary
This early-stage study aimed to see if a three-part combination treatment could help people with HIV achieve remission, meaning they could stop their daily antiviral medications and keep the virus under control. The treatment combined a therapeutic vaccine, a lab-made antibody, and a drug meant to 'wake up' hidden virus. The study was designed for adults with well-controlled HIV on stable medication, but it was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.